← FDA DRUG APPROVALS

FDA ANDA · ANDA089104

THIORIDAZINE HYDROCHLORIDE

Sponsor: SUPERPHARM

APPLICATION
ANDA089104
TYPE
ANDA
ORIGINAL APPROVAL
1985-07-02
LATEST ACTION
1991-06-19
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

THIORIDAZINE HYDROCHLORIDEDiscontinued
THIORIDAZINE HYDROCHLORIDE 25MG · TABLET · ORAL

Approval history

1991-06-19Labeling · Supplement 17AP
1989-02-08Labeling · Supplement 13AP
1985-07-02OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →